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Background: Electrocardiographic early repolarization (ER) occurring in <5% of
general/atherosclerotic populations, is a marker of sudden cardiac death (SCD). The
prevalence of ER in chronic kidney disease (CKD) patients, in whom SCD is common,
is unknown. We aimed to determine the prevalence, contributing factors, and relationship
of ER to all-cause mortality and progression to dialysis in CKD patients.
Methods: A retrospective study of 197 patients with stage 3–5 CKD. Full demographic
data were collected including cardiovascular risk factors and history. All patients
underwent a 12-lead ECG, analysed for the presence of ER and other ECG findings. ER
was defined as elevation of the QRS-ST junction (J point) by at least 0.1mV from baseline
with slurring/notching of the QRS complex. The primary and secondary endpoints were all
cause mortality and progression to dialysis respectively at 1 year. To control for the effects
of CKD, we evaluated the ECGs of 39 healthy renal transplant donors (RTD).
Results: CKD patients had a mean age of 61.5 (±16.1). Prevalence of ER in pre-dialysis
patients with CKD stage 4 and 5 was higher than in RTD (26.4 vs. 7.7%, p = 0.02). ER
frequency increased with CKD stage (stage 3: 7.7%, stage 4: 29.7%, and pre-dialysis
stage 5: 24.6%), but decreased in dialysis patients (13%). On multivariate analysis only the
QRS duration was a significant independent predictor of ER (OR 0.97, 95% CI, 0.94–0.99,
p = 0.01). At 1-year follow-up, there were 24 (12%) deaths in the patients with CKD of
whom 5 (21%) had ER. ER was not a predictor of all cause mortality (p = 1.00) and had
no effects on the rate of progression to dialysis (p = 0.67).
Conclusions: ER is more common in pre-dialysis CKD patients, compared to healthy RTD
but is not associated with increased 1-year mortality or entry onto dialysis programs.
Further longitudinal studies are indicated to determine whether this increased prevalence
of ER is associated with the rate of SCD seen in this population.
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INTRODUCTION
The renal and cardiovascular systems have a unique and intri-
cate inter-relationship, with disease or dysfunction in one organ
frequently leading to injury in the other. This complex inter-
action has led to the use of the term “cardio-renal syndrome”
(Ronco et al., 2009; Hajhosseiny et al., 2013). Overall, for sub-
jects with chronic kidney disease (CKD) stage 3, it is more likely
that a patient will develop cardiovascular disease (CVD) than
progress to dialysis-requiring renal failure (CKD stage 5D; Bleyer
et al., 2006; Hajhosseiny et al., 2013). Sudden cardiac death (SCD)
is particularly prevalent amongst patients with CKD, with esti-
mates ranging from 25 to 60% (Herzog, 2003; Pun et al., 2009).
Abbreviations: CKD, chronic kidney disease; ECG, 12-lead electrocardiogram;
ER, early repolarization; SCD, sudden cardiac death.
In dialysis patients, the incidence of SCD is very high; eclipsing
other causes of cardiac death, and rises with both the duration
of time that the patient has been on a dialysis program, as well
as the severity and frequency of dialysis-associated electrolyte
imbalances (Karnik et al., 2001; Bleyer et al., 2006).
Until recently, electrocardiographic early repolarization (ER)
was considered a benign finding on a patient’s electrocardiogram
(ECG). However, a number of recent studies have suggested that
ER may represent an independent marker of sudden arrhyth-
mic cardiac arrest in otherwise healthy individuals (Haissaguerre
et al., 2008; Ghosh et al., 2010; Sinner et al., 2010; Tikkanen et al.,
2012). Despite this, it is currently unknown whether or not there
is a similar increased prevalence of ER in CKD patients in whom
SCD is common. The aim of the current study was therefore to
determine the prevalence of ER, possible contributory factors,
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and whether or not ER is related to all-cause mortality and
progression to dialysis in patients with CKD.
METHODS
PATIENTS
We retrospectively studied adults with stage 3–5 CKD referred to
the Nephrology department at Guy’s and St. Thomas’ Hospital
between March 2007 and December 2011. Our study popula-
tion consisted of newly diagnosed patients with CKD, or patients
with follow-up appointments. In addition, we also studied 39
adults without CKD to control for the effects of renal failure on
ER. These controls were healthy renal transplant donors (RTD)
with no documentation of structural heart disease or a history
of syncope. Full demographic data pertaining to cardiovascu-
lar risk factors, prior cardiac history, current medications, and
concurrent co-morbidities were recorded along with recent lab-
oratory results (renal profile, serum calcium, and hs C-reactive
protein levels). Cardiovascular risk factors were determined by
pre-set defined criteria. Hypertension was defined as a systolic
blood pressure of >140mmHg, a diastolic blood pressure of
>90mmHg, or antihypertensive drug use. Smoking was defined
as a current smoker or past heavy smoker (>20 package-years).
Diabetes mellitus was defined as a previously established diag-
nosis, insulin, or oral hypoglycemic therapy, fasting glucose
of >126mg/dL, or non-fasting glucose of >200mg/dL. Family
history of coronary artery disease was defined as myocardial
infarction, coronary revascularization, or SCD in a first-degree
relative <65 years old. A 12-lead ECG was performed on all
patients and the primary inclusion criteria were based on CKD
severity and the availability of a recent adequate ECG recording
in their clinical file. Patients with permanent pacemakers were
excluded from the study. All patients were followed up for a min-
imum time period of 12-months from the data of the first ECG.
Written informed consent was obtained from the 19 haemodial-
ysis patients for obtaining an ECG before and after dialysis and
the study was granted institutional ethics committee approval in
accordance with theHelsinki Declaration (1964, amended in 1975
and in 1984).
ECG ACQUISITION AND ANALYSIS
All patients underwent a 12-lead ECG. These were fully inter-
rogated by two electrophysiologists blinded to the clinical data
for relevant electrical intervals (PR, QRS, and QTc durations),
and for bundle branch block, the cardiac axis, left ventricular
hypertrophy (LVH), and ER. The presence or absence of LVH
was assessed according to the Sokolow–Lyon criteria and the QT
interval was corrected for heart rate according to Bazett’s formula.
Early repolarization was defined as an elevation of the QRS-ST
junction (J point) in at least two leads. The amplitude of J-point
elevation had to be at least 1mm (0.1mV) above the baseline
level either as QRS slurring (a smooth transition from the QRS
segment to the ST segment—Figure 1A) or notching (a positive
J deflection inscribed on the S wave—Figure 1B) in the inferior
leads (II, III, and aVF), lateral leads (I, aVL, and V4–V6), or both.
The anterior precordial leads (V1–V3) were excluded from the
analysis to avoid the inclusion of patients with right ventricular
dysplasia or Brugada syndrome. In order to account for the effects
FIGURE 1 | The identification of ER from the 12-lead
electrocardiogram. (A) Shows a typical example of a slurred patterned ER
(arrows) while (B) shows the appearance of a notched ER (arrows).
of dialysis on ER, we obtained an ECG recording from 19 patients
on hemodialysis immediately prior to the start of their dialysis
session, and followed this up with the acquisition of another ECG
immediately after their dialysis session had finished.
FOLLOW UP
In order to investigate the prognostic and predictive value of
ER, all patients (CKD and controls) were followed up for 12
months from the start of the study. The primary endpoint was all-
cause mortality (all cause) and the secondary endpoint, the new
commencement of dialysis.
STATISTICAL ANALYSIS
All continuous variables included in the analysis are presented
as mean ± SD. Variables with non-normal distributions are pre-
sented as median with range. Univariate analyses were performed
on continuous variables using the two-sample t-test for nor-
mally distributed variables and the Mann–Whitney U test for
non-normally distributed data. Spearman’s correlation coefficient
was used to assess the relationship between continuous vari-
ables. Multivariable logistic regression was used to determine
the predictors of ER using age, presence of COPD, mineralo-
corticoid receptor antagonist use, heart rate, PR interval, QRS
interval, and dialysis as covariates. Statistical significance for
all analyses was set at the 5% level. All data were collected
and analyzed using SPSS for MAC (Version 19, IBM, Somers,
NY, USA).
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RESULTS
The baseline demographics of the population are given in
Table 1. There were 202 patients with CKD stage 3–5 who were
approached for inclusion into the study. Of these, 5 patients were
excluded due to the presence of a permanent cardiac pacemaker.
In the remaining cohort of 197 patients, the ethnic origin was
Caucasian in 121 (61%), Afro-Caribbean in 60 (31%), and South
Asian in 16 (8%). There was a prior cardiac history present in
62 (32%) patients [8 (4%) congestive cardiac failure, 47 (24%)
coronary artery disease, 14 (16%) myocardial infarction, 8 (4%)
valvular heart disease and 14 (7%) atrial fibrillation].
PREVALENCE OF EARLY REPOLARIZATION IN PATIENTSWITH AND
WITHOUT CKD
Table 2 gives the comparison of baseline demographics between
the 197 patients with CKD and the 39 healthy renal donors who
represented the control group. The healthy renal donors were
of a younger age and were predominantly Caucasian in ethnic
origin. Although there was a tendency to an increased preva-
lence of ER in the CKD population (19.8%) compared with the
renal donors (7.7%), this did not reach statistical significance
(P = 0.07). There was no difference observed in themagnitude or
distribution of J-point elevation. Prevalence of ER in pre-dialysis
patients with CKD stage 4 and 5 was higher than in the RTD (26.4
vs. 7.7%, p = 0.02). Early repolarization frequency increased with
CKD stage (stage 3: 7.7%, stage 4: 29.7%, and pre-dialysis stage 5:
24.6%), but decreased in dialysis patients (13%).
PREDICTORS OF EARLY REPOLARIZATION
In the CKD group of patients, age, gender, ethnicity, prior car-
diac history, cardiovascular risk factors, eGFR, and CKD stage
were unrelated to the presence of ER (Table 3). Similarly, there
was no relationship to the use of cardiac medications or serum
electrolytes and biochemistry. There were however a number of
ECG predictors of ER. Patients with ER had lower heart rates (HR
with ER 71 ± 15 BPM vs. 77 ± 17 without ER, p = 0.03), shorter
QRS durations (QRS duration with ER 84 ± 11 vs. 94 ± 21 with-
out ER, p < 0.01), and shorter QTc durations (QTc duration
with ER 412 ± 22 vs. 427 ± 34 without ER, p < 0.001). On mul-
tivariate analysis (Table 4) with ER as the dependent variable and
age, presence of COPD, mineralocorticoid receptor antagonist
use, heart rate, PR interval, QRS interval, and dialysis as covari-
ates, only the QRS duration remained a significant independent
predictor of ER (OR 0.97, 95% CI, 0.94–0.99, p = 0.01).
EARLY REPOLARIZATION AS A PREDICTOR OF ALL-CAUSE MORTALITY
AND PROGRESSION TO DIALYSIS
At 1-year follow-up, there were 24 deaths. There was no dif-
ference in mortality between those who had ER 13% (5 of 39
patients) to those who did not 12% (19 of 158 patients), p = 1.0
(Figure 2). From the 119 patients who were not already on dialy-
sis at the study commencement, 56 (47%) patients progressed to
either peritoneal or hemodialysis. Of the 29 patients with ER who
were not yet on dialysis, 15 (52%) progressed to renal replacement
therapy, compared with 41 (46%) of the 90 patients without ER
(p = 0.67).
Table 1 | Baseline characteristics of patients with CKD.
CKD (N = 197)
Age (years) 61.5± 16.1
Gender (male) n (%) 113 (57)
eGFR (mL/min/1.73m2) 14.0 (10.0–17.3)
CKD STAGE n (%)
3 13 (6.6)
4 37 (18.8)
5 no dialysis 69 (35.0)
5 dialysis 78 (39.6)
Renal Transplant n (%) 16 (8.1)
Duration of CKD (months) 25 (12–54)
Stroke n (%) 19 (9.6)
COPD n (%) 11 (5.6)
CARDIOVASCULAR RISK FACTOR n (%)
Diabetes 77 (39.1)
BMI (kg/m2) 28.8± 6.6
Current smoker 4 (2)
Dyslipidaemia 33 (16.8)
Hypertension 133 (67.5)
Systolic blood pressure (mmHg) 145± 25
Diastolic blood pressure (mmHg) 75± 15
MEDICATIONS n (%)
β blockers 73 (37.1)
Diuretics 72 (36.5)
Aldosterone antagonist 4 (2.0)
ACE inhibitors 53 (26.9)
ARB 49 (24.9)
CCB 4 (2.0)
Amiodarone 1 (0.5)
Statins 106 (53.8)
Erythropoietin 112 (56.9)
BIOCHEMICAL
Potassium (mmol/L) 4.7± 0.7
Calcium (mmol/L) 2.3± 0.3
Phosphate (mmol/L) 1.4± 0.4
Parathormone (PTH) 191 (97–396)
CRP 6 (5–20)
Hemoglobin (g/dL) 10.8± 1.9
ELECTROCARDIOGRAM
Heart rate (bpm) 76± 17
PR duration (ms) 162± 49
QRS duration (ms) 92± 20
QRS axis (◦) 17.3± 41.5
Right BBB n (%) 11 (5.6)
Left BBB n (%) 6 (3.0)
Electrical LVH n (%) 33 (16.8)
QTc duration (ms) 424± 32
Abbreviations: ACE-I, angiotensin converting enzyme inhibitors; ARB,
angiotensin receptor blockers; BMI, body mass index; CKD, chronic kidney
disease; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein;
PTH, parathyroid hormone.
DISCUSSION
The main finding of the current study is that there is an increased
prevalence of ER in CKD patients (20%) when compared to
healthy controls (8%). We also show that the presence of ER is
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Table 2 | Comparison of baseline characteristics of patients with CKD
vs. the renal transplant donors.
CKD Donors p
(n = 197) (n = 39)
Age (years) 61.5± 16.1 44.0± 11.6 <0.0001
ETHNICITY
Caucasian n (%) 121 (61.4) 35 (89.7) 0.0001
Afro-Caribbean n (%) 60 (30.5) 1 (2.6)
Asian n (%) 16 (8.1) 3 (7.7)
Gender (male) n (%) 113 (57.4) 20 (51.3) 0.48
Height (cm) 167 ± 10 170 ± 9 0.04
Weight (kg) 81 ± 21 76 ± 13 0.13
eGFR (mL/min/1.73m2) 14 (10–20) 85 (79–92) <0.0001
Early repolarization n (%) 39 (19.8) 3 (7.7) 0.07
PATTERN n (%)
Slurred 26 (66.7) 2 (66.7) 1.00
Notch 13 (33.3) 1 (33.3)
J POINT ELEVATION n (%)
≥0.1 and <0.2mV 38 (97.4) 3 (100.0) 1.00
≥0.2mV 1 (2.6) 0 (0.0)
LOCALIZATION n (%)
Inferior 16 (41.0) 0 (0.0) 0.22
Lateral 14 (35.9) 3 (100.0)
Inferior and lateral 9 (23.1) 0 (0.0)
Abbreviations: eGFR, estimated glomerular filtration rate.
associated to a shorter QRS duration in patients with CKD but
that this did not translate to an increased incidence of all-cause
mortality or progression to dialysis at 1-year follow-up.
A number of prior studies have suggested a relationship
between the presence of ER and SCD. Haissaguerre et al. (2008)
conducted amulticentre study of 206 patients resuscitated after an
episode of idiopathic ventricular fibrillation. The authors found
that there was an increased prevalence of ER (31%) when com-
pared to 412 age, gender, and race matched controls (5%), and
that after a median follow-up of 61 months patients with ER
had a significantly higher incidence of ventricular fibrillation than
those cases without ER (HR 2.1, 95% CI 1.2–3.5, p = 0.008). In
another study of 432 victims of a SCD from an acute coronary
event Tikkanen et al. (2012), showed that there was an increased
prevalence of ER (14.4%) when compared to 532 survivors of an
acute coronary syndrome (7.9%). Finally, in a study of 1945 indi-
viduals aged between 35 and 74 years of age (Sinner et al., 2010),
found a greater than 2-fold-increased risk of cardiac mortality in
participants with ER compared to individuals without ER.
Although the exact mechanism of ER-induced arrhythmo-
genicity is still unclear, it has been hypothesized that this may be
related to either an increased susceptibility or vulnerability to car-
diac arrest in critical ischemic conditions such as acute coronary
syndromes (Tikkanen et al., 2012), or to subtle changes in the car-
diac action potential (Benito et al., 2010). Early repolarization in
its simplest form occurs in Phase 1 of the cardiac action potential
and is caused by the cardiac transient outward potassium current
(Ito). If a situation arises where there is a reduced density of the
Table 3 | Comparison of baseline characteristics of adults with ER vs.
those without ER.
Overall ER No ER p
(N = 197) (N = 39) (N = 158)
Age (years) 61.5± 16.1 58.1± 17.1 62.3± 15.8 0.14
Male n (%) 113 (57.4) 22 (56.4) 91 (57.6) 0.89
ETHNICITY n (%)
Caucasian n (%) 121(61.4) 74 (61.2) 47 (38.8) 0.91
Afro-Caribbean n (%) 60 (30.5) 31 (51.7) 29 (48.3)
Asian n (%) 16 (8.1) 8 (50.0) 8 (50.0)
CARDIAC HISTORY n (%)
Congestive heart
failure
8 (4.1) 2 (5.1) 6 (3.8) 0.66
Palpitations 1 (0.5) 1 (2.6) 0 (0) 0.20
Syncope 1 (0.5) 0 (0) 1 (0.6) 1.00
SCD 0 (0) 0 (0) 0 (0) N/A
Coronary artery
disease
47 (23.9) 8 (20.5) 39 (24.7) 0.58
Myocardial infarction 14 (16.1) 1 (2.6) 13 (8.2) 0.31
PCI 18 (9.1) 3 (7.7) 15 (9.5) 0.72
CABG 8 (4.1) 1 (2.6) 7 (4.4) 0.59
Other* 26 (13.2) 5 (12.8) 21 (13.3) 1.00
eGFR
(mL/min/1.73m2)
10.0 ± 7.2 12.0 ± 9.2 10 ± 7–17.0 0.38
CKD STAGE n (%)
3 13 (6.6) 1 (2.6) 12 (7.6) 0.07
4 37 (18.8) 11 (28.2) 26 (16.5)
5 no dialysis 69 (35.0) 17 (43.6) 52 (32.9)
5 dialysis 78 (39.6) 10 (5.1) 68 (43.0)
Renal dialysis n (%) 78 (39.6) 10 (25.6) 68 (43.0) 0.046
Renal transplant n (%) 16 (8.1) 3 (7.7) 13 (8.2) 0.91
CKD duration
(months)
25 (12–54) 30 (11–57) 25 (12–64) 0.61
Stroke n (%) 19 (9.6) 3 (7.7) 16 (10.1) 0.77
COPD n (%) 11 (5.6) 0 (0) 11 (7.0) 0.13
CV RISK FACTORS n (%)
Diabetes 77 (39.1) 16 (41.6) 61 (38.6) 0.78
BMI (kg/m2) 29 ± 7 29± 7 29± 7 0.86
Current smoker 4 (2) 1 (2.6) 3 (1.9) 1.00
Dyslipidaemia 33 (16.8) 7 (17.9) 26 (16.5) 0.82
Hypertension 133 (67.5) 25 (64.1) 108 (68.4) 0.61
SBP (mmHg) 145± 25 141± 22 146± 26 0.35
DBP (mmHg) 75 ± 15 76 ± 13 75± 15 0.76
MEDICATIONS n (%)
β blockers 73 (37.1) 16 (41.0) 57 (36.1) 0.56
Diuretics 72 (36.5) 17 (43.6) 55 (34.8) 0.31
MRA 4 (2.0) 2 (5.1) 2 (1.3) 0.17
ACE inhibitors 53 (26.9) 8 (20.5) 45 (28.5) 0.31
ARB 49 (24.9) 10 (25.6) 39 (24.7) 0.90
CCB 4 (2.0) 0 (0) 4 (2.5) 0.59
Amiodarone 1 (0.5) 0 (0) 1 (0.6) 1.00
Statins 106 (53.8) 19 (48.7) 87 (55.1) 0.48
Erythropoietin 112 (56.9) 18 (46.2) 94 (59.5) 0.13
(Continued)
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Table 3 | Continued
Overall ER No ER p
(N = 197) (N = 39) (N = 158)
BIOCHEMISTRY
Potassium (mmol/L) 4.7 ± 0.7 4.8 ± 0.6 4.7 ± 0.8 0.34
Calcium (mmol/L) 2.3 ± 0.3 2.3± 0.2 2.3 ± 0.3 0.51
Phosphate (mmol/L) 1.4 ± 0.4 1.4 ± 0.4 1.4 ± 0.4 0.68
Parathormone (PTH) 191 (97–396) 221 (100–368) 183 (97–404) 0.92
CRP 6 (5–20) 6 (5–12) 6 (5–24) 0.30
Hemoglobin (g/dL) 10.8 ± 1.9 10.8 ± 1.9 10.7 ± 1.9 0.82
ELECTROCARDIOGRAM
Heart Rate (bpm) 76 ± 17 71 ± 15 77± 17 0.03
PR duration (ms) 162± 49 172 ± 29 160± 52 0.18
QRS duration (ms) 92± 20 84 ± 11 94± 21 <0.01
QRS axis (◦) 17.3 ± 41.5 27.0± 25.0 15.0± 44.4 0.03
Right BBB n (%) 11 (5.6) 1 (2.6) 10 (6.3) 0.70
Left BBB n (%) 6 (3.0) 0 (0) 6 (3.8) 0.60
Electrical LVH n (%) 33 (16.8) 5 (12.8) 28 (17.7) 0.46
QTc duration (ms) 424± 32 412± 22 427± 34 <0.001
Abbreviations: BBB, bundle branch block; CABG, coronary artery bypass graft;
CCB, calcium channel blocker; DBP, diastolic blood pressure; ICD, implantable
cardiac defibrillator; MRA, mineralocorticoid receptor antagonist; PCI, percuta-
neous coronary intervention; SBP, systolic blood pressure; SCD, sudden cardiac
death.
*Atrial fibrillation, ICD, Valvular heart disease, Ventricular tachycardia.
Table 4 | Multivariate logistic regression analyses for the predictors
of ER.
OR (95% CI) p
Age 0.98 (0.96, 1.01) 0.20
COPD 0.00 (0.00, 0.00) 1.00
Anti-aldosterone 7.95 (0.40, 158.48) 0.18
Heart rate 0.98 (0.95, 1.00) 0.76
PR interval 1.01 (1.00, 1.02) 0.28
QRS duration 0.97 (0.94, 0.99) 0.01
Dialysis 0.55 (0.24, 1.27) 0.16
FIGURE 2 | Kaplan Meier Curve comparing 1-year survival in CKD
patients with ER, without ER, and the renal transplant donors (RTD).
Ito channels in the endocardium compared with epicardium or
mid-myocardium (Li et al., 2002), a large Ito current can occur
that results in electrocardiographic ER and large voltage gradients
that have the propensity to initiate life threatening arrhythmias
(Li et al., 2002; Benito et al., 2010). In addition, an increase
in transmural dispersion of ventricular repolarization, which is
associated with ER (Karim Talib et al., 2012), has been demon-
strated in patients with CKD (Tun et al., 1991; Saravanan and
Davidson, 2010). This increasemay partially explain the increased
prevalence of ER in our CKD population.
In the current study, although we showed an increased preva-
lence of ER in patients with CKD, this was not associated with
either all-cause mortality at 1-year or progression to dialysis.
There are a number of potential explanations for this finding.
The sample size in the current study was modest in comparison
to prior studies and it is possible that any true effect of ER on
mortality or progression to dialysis was concealed. It is also pos-
sible that CKD patients represent an entirely different cohort of
patients to that previously studied and that the presence of ER
may not be of prognostic importance. Further studies of larger
cohorts of patients with CKD are indicated to clarify the findings
of the current study.
Interestingly we also showed on univariate analysis that the
presence of ER was related to a slower heart rate and shorter
QRS and QTc durations. Although slower heart rates have been
shown to be associated with ER (Li et al., 2002; Benito et al.,
2010), potentially as a result of time-dependent recovery of Ito
from inactivation (Antzelevitch and Yan, 2010; Benito et al.,
2010), the finding of an association of a shorter QRS duration
to an increased prevalence of ER is discrepant with prior stud-
ies. (Tikkanen et al., 2009, 2012) showed that ER was related to
a slight increase in the QRS duration, while Haissaguerre et al.
(2008) found no relationship between ER and QRS duration. It
is possible that in the current study a broader QRS duration may
have masked subtle J point elevation making the significance of
this finding difficult to interpret. In keeping with prior reports
(Haissaguerre et al., 2008; Watanabe et al., 2010) we also showed
that a shorter QTc interval was associated to ER supporting the
hypothesis that ER and short QT syndrome may share common
cardiac channel genetic mutations (Watanabe et al., 2010).
If ER is shown to be prognostically important in CKD, there
are potential therapeutical applications: antiarrhythmic drugs
such as isoproterenol and quinidine have been shown to reduce
ER or even restore normal ECG patterns (Haissaguerre et al.,
2009). Further, this electrocardiographic marker could contribute
to risk stratification tools to guide ICD therapy in high risk
patients.
STUDY LIMITATIONS
There are a number of limitations to the current study. The sam-
ple size was relatively small with a low incidence of mortality
and progression to dialysis. This may have concealed any poten-
tial adverse effects of having ER. The retrospective design of the
study did not permit the demonstration of any potential tempo-
ral relationships between CKD and ER or adverse clinical events.
There was a difference between the ethnic origin of the patients
with CKD and the RTD that were used as controls. This may have
www.frontiersin.org May 2013 | Volume 4 | Article 127 | 5
Hajhosseiny et al. Electrocardiographic early repolarisation in CKD
magnified the differences in prevalence of ER between the two
groups with prior studies having shown an increased prevalence
of ER in patients of Afro-Caribbean origin. Furthermore, a sig-
nificant proportion of our cohort had a previous cardiac history,
which has been associated with ER. Therefore, we may have over-
estimated the prevalence of ER in our population. However, on
closer analysis of these patients, we found no significant associ-
ation between previous cardiac history and the presence of ER.
Finally owing to the study design, only a single ECG was avail-
able for analysis for each patient and it is unknown whether
the presence of ER was a fixed or more dynamic electrocar-
diographic finding during the study period. Further studies are
indicated to confirm our findings in a larger cohort of patients
with CKD and also to assess for serial electrocardiographic
changes.
CONCLUSIONS
Electrocardiographic early repolarization is more common in
patients with pre-dialysis CKD compared to healthy RTD.
However, this increased prevalence of ER was not associated
with increased 1-year mortality or entry onto dialysis programs.
Further longitudinal studies are indicated to determine whether
this increased prevalence of ER is associated with the increased
rate of SCD observed in this population.
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